Stories | Patient Daily

Technology/Innovation

+ Technology/Innovation

Press release submission | Oct 11, 2019

BRAINOMIX: Using Simple Brain Scans Brainomix AI Software Can Generate Critical Information for the Treatment of Stroke Patients

+ Technology/Innovation

Press release submission | Oct 8, 2019

AMERICAN SOCIETY FOR AESTHETIC PLASTIC SURGERY: The Aesthetic Society Develops 'The Patient App' Through Support From Allergan®

Press release submission | Oct 5, 2019

AAPS: President Trump Gives Patients More Options to Escape Government-Run Medicine, States the Association of American Physicians and Surgeons (AAPS)

+ Technology/Innovation

Press release submission | Oct 4, 2019

GT BIOPHARMA: Announces HIV TriKE™ Data Demonstrating NK Cell Killing of Patient HIV Infected Cells

+ Technology/Innovation

Press release submission | Sep 24, 2019

MALLINCKRODT: Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft® Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns

+ Technology/Innovation

Press release submission | Sep 23, 2019

MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care

Press release submission | Sep 19, 2019

ORACLE NETSUITE: Medical supplier expands its mission to deliver pain-free recovery to 5 million patients

Press release submission | Sep 16, 2019

SELF CARE CATALYSTS: Canadian Breast Cancer Network and Self Care Catalysts Forged Strategic Partnership to Provide Digital Patient Support Tools for Breast Cancer Patients

Trending

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals

Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals

Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones